In case you're not convinced: Another study showed HCQ protects SLE pts from death. Risk reduction in those taking antimalarials 83% vs. those who cannot take the drug (for any reason) 42%, yet 60% of patients are non-adherent -study reviewed by Prof Dorner #EULAR2021 @rheumnow https://t.co/zBgCLipHPP